Literature DB >> 22966483

Liver transplantation in adults: Choosing the appropriate timing.

Maria Siciliano1, Lucia Parlati, Federica Maldarelli, Massimo Rossi, Stefano Ginanni Corradini.   

Abstract

Liver transplantation is indicated in patients with acute liver failure, decompensated cirrhosis, hepatocellular carcinoma and rare liver-based genetic defects that trigger damage of other organs. Early referral to a transplant center is crucial in acute liver failure due to the high mortality with medical therapy and its unpredictable evolution. Referral to a transplant center should be considered when at least one complication of cirrhosis occurs during its natural history. However, because of the shortage of organ donors and the short-term mortality after liver transplantation on one hand and the possibility of managing the complications of cirrhosis with other treatments on the other, patients are carefully selected by the transplant center to ensure that transplantation is indicated and that there are no medical, surgical and psychological contraindications. Patients approved for transplantation are placed on the transplant waiting list and prioritized according to disease severity. Thus, the appropriate timing of transplantation depends on recipient disease severity and, although this is still a matter of debate, also on donor quality. These two variables are known to determine the "transplant benefit" (i.e., when the expected patient survival is better with, than without, transplantation) and should guide donor allocation.

Entities:  

Keywords:  Allocation; Cirrhosis; Contraindications; Hepatocellular carcinoma; Indications; Liver transplantation; Prioritization; Referral; Timing; Waiting list

Year:  2012        PMID: 22966483      PMCID: PMC3437446          DOI: 10.4292/wjgpt.v3.i4.49

Source DB:  PubMed          Journal:  World J Gastrointest Pharmacol Ther        ISSN: 2150-5349


  127 in total

Review 1.  Liver transplantation for primary biliary cirrhosis: indications and risk of recurrence.

Authors:  James Neuberger
Journal:  J Hepatol       Date:  2003-08       Impact factor: 25.083

2.  Incidence and recurrence of autoimmune/alloimmune hepatitis in liver transplant recipients.

Authors:  Ernesto P Molmenti; George J Netto; Natalie G Murray; Douglas M Smith; Hebe Molmenti; Jeffrey S Crippin; Tyrone C Hoover; Ghapjoong Jung; Shigeru Marubashi; Edmund Q Sanchez; Brian Gogel; Marlon F Levy; Robert M Goldstein; Carlos G Fasola; Thomas A Gonwa; Goran B Klintmalm
Journal:  Liver Transpl       Date:  2002-06       Impact factor: 5.799

3.  Cryptogenic cirrhosis and posttransplantation nonalcoholic fatty liver disease.

Authors:  J Ong; Z M Younossi; V Reddy; L L Price; T Gramlich; J Mayes; N Boparai
Journal:  Liver Transpl       Date:  2001-09       Impact factor: 5.799

4.  Effect of lamivudine treatment on survival of 309 North American patients awaiting liver transplantation for chronic hepatitis B.

Authors:  Robert J Fontana; Emmet B Keeffe; William Carey; Michael Fried; Rajender Reddy; Kris V Kowdley; Consuelo Soldevila-Pico; Leslie A McClure; Anna S F Lok
Journal:  Liver Transpl       Date:  2002-05       Impact factor: 5.799

5.  Liver transplantation for alcoholic cirrhosis: long term follow-up and impact of disease recurrence.

Authors:  C O Bellamy; A M DiMartini; K Ruppert; A Jain; F Dodson; M Torbenson; T E Starzl; J J Fung; A J Demetris
Journal:  Transplantation       Date:  2001-08-27       Impact factor: 4.939

Review 6.  Donor morbidity associated with right lobectomy for living donor liver transplantation to adult recipients: a systematic review.

Authors:  Kimberly L Beavers; Robert S Sandler; Roshan Shrestha
Journal:  Liver Transpl       Date:  2002-02       Impact factor: 5.799

7.  Early death from paracetamol (acetaminophen) induced fulminant hepatic failure without cerebral oedema.

Authors:  P Aiden McCormick; Darren Treanor; Geraldine McCormack; Michael Farrell
Journal:  J Hepatol       Date:  2003-10       Impact factor: 25.083

8.  Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis.

Authors:  Peter Schenk; Maximilian Schöniger-Hekele; Valentin Fuhrmann; Christian Madl; Gerd Silberhumer; Christian Müller
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

9.  A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation.

Authors:  Nicholas N Onaca; Marlon F Levy; Edmund Q Sanchez; Srinath Chinnakotla; Carlos G Fasola; Mark J Thomas; Jeffrey S Weinstein; Natalie G Murray; Robert M Goldstein; Goran B Klintmalm
Journal:  Liver Transpl       Date:  2003-02       Impact factor: 5.799

Review 10.  Prevention of recurrent hepatitis B post-liver transplantation.

Authors:  Anna S f Lok
Journal:  Liver Transpl       Date:  2002-10       Impact factor: 5.799

View more
  1 in total

1.  Factors Associated with Mortality and Graft Failure in Liver Transplants: A Hierarchical Approach.

Authors:  Luciana Haddad; Alex Jones Flores Cassenote; Wellington Andraus; Rodrigo Bronze de Martino; Neli Regina de Siqueira Ortega; Jair Minoro Abe; Luiz Augusto Carneiro D'Albuquerque
Journal:  PLoS One       Date:  2015-08-14       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.